RENASYS-G 15Fr Channel Drain Gauze Dressing Kit (66802257); RENASYS 15Fr Channel Drain Accessory Kit (66802253)
Smith & Nephew Medical, Ltd. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-30 for K260306, a traditional 510(k) submitted by Smith & Nephew Medical, Ltd. of Hull, GB. The filing covers the RENASYS-G 15Fr Channel Drain Gauze Dressing Kit (66802257) and the RENASYS 15Fr Channel Drain Accessory Kit (66802253), classified under product code OMP as a Negative Pressure Wound Therapy Powered Suction Pump, regulation 878.4780, in the General & Plastic Surgery specialty. SESE means clearance to market, not PMA approval.
The record shows a receipt date of 01/30/2026, no third-party review, no combination product status and no authorized predetermined change control plan. The listed predicate device, the specific differences between these kits and that predicate, and any supporting performance data are not present in the retrieved page, so the basis for the equivalence finding remains unknown from this source.
The page carries no summary statement text, so indications, contraindications and labeling scope for these kits cannot be described here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260306
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Smith & Nephew Medical, Ltd.
- Product code
- OMP
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Negative Pressure Wound Therapy Powered Suction Pump.
- Applicant
- Smith & Nephew Medical, Ltd.
- Product code
- OMP
- FDA device class
- 2
FDA decision timeline
K260306 received
Application receipt date recorded by FDA.
K260306 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OMP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bechtel Medical, Inc. | 510(k) clearance | Nov 6, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Oct 23, 2026 | FDA | |
MeCare Alpha (MCA2019)K260426 | IVT Medical, Ltd. | 510(k) clearance | Oct 8, 2026 | FDA |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Smith & Nephew Medical, Ltd.
- Headquarters
- Not reported
- Brand website
- smith-nephew.com
- FDA applicant address
- Hull
Sources and methodology
- Original FDA record: K260306
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

